| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Li,Pei-Lin | Chairman | 3.85% | |
| Li,Dian-Ying | Vice Chairman | 5.64% | |
| Huang,Jun-Xiong | Director | 0.00% | |
| Zhuang,Yong-Shun | Director | 0.25% | |
| Liao,Geng-Wang | Independent Director | 0.00% | |
| Chi,Ji | Independent Director | 0.00% | |
| Gao,Ming-Liang | Independent Director | 0.00% |
Change Company Name to CHC Healthcare Group
2024/04/29
Change Company Name to CHENGYE BIOMEDICAL INVESTMENT HOLDINGS CO., LTD. (FORMER NAME: CHENGYE INVESTMENT HOLDINGS CO., LTD.)
2022/08/12
Change Capital to 2,500,000,000
2019/07/01
Change Capital to 2,000,000,000
2013/10/11
Change Company Name to CHC Healthcare Group
2012/01/31
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating income | 3,600,574 | 3,877,137 | 2,974,352 |
| Operating cost | 2,841,449 | 2,808,977 | 2,072,038 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 759,125 | 1,068,160 | 902,314 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 759,125 | 1,068,160 | 902,314 |
| Operating expenses | 520,415 | 454,684 | 426,554 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | 238,710 | 613,476 | 475,760 |
| Non-operating income and expenses | -15,703 | -54,046 | 8,075 |
| Net profit (loss) before tax | 223,007 | 559,430 | 483,835 |
| Income tax expense (benefits) | 40,430 | 134,192 | 95,185 |
| Net profit (loss) of ongoing business for the current period | 182,577 | 425,238 | 388,650 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 182,577 | 425,238 | 388,650 |
| Other comprehensive profit (loss), net | 18,085 | 1,692 | 8,349 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 200,662 | 426,930 | 396,999 |
| Net profit (loss) attributable to owners of parent company | 168,384 | 418,866 | 356,571 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | 14,193 | 6,372 | 32,079 |
| Comprehensive profit (loss) attributable to owners of parent company | 185,552 | 420,625 | 364,855 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | 15,110 | 6,305 | 32,144 |
| Basic earnings per share (yuan) | 1 | 2 | 2 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | 99,367 | 962,588 | 656,659 |
| Net cash inflows (outflows) from investing activities | -544,855 | -500,465 | -339,979 |
| Net cash inflow (outflow) from financing activities | 188,238 | -42,048 | -346,452 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 7,652 | -1,543 | 8,694 |
| Increase (decrease) in cash and cash equivalents in the current period | -249,598 | 418,532 | -21,078 |
| Beginning balance of cash and cash equivalents | 1,891,381 | 1,472,849 | 1,493,927 |
| Ending balance of cash and cash equivalents | 1,641,783 | 1,891,381 | 1,472,849 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current asset | 4,767,714 | 4,331,689 | 3,851,549 |
| Non-current asset | 9,446,743 | 9,281,738 | 8,979,352 |
| Total asset | 14,214,457 | 13,613,427 | 12,830,901 |
| Current liability | 3,493,579 | 1,426,005 | 1,054,032 |
| Non-current liability | 4,048,394 | 5,411,916 | 5,373,773 |
| Total liability | 7,541,973 | 6,837,921 | 6,427,805 |
| share capital | 1,668,651 | 1,664,194 | 1,615,531 |
| Equity - secruity token | - | - | - |
| capital reserve | 3,732,745 | 3,716,656 | 3,544,423 |
| retained earning | 1,297,016 | 1,463,229 | 1,369,085 |
| Other equity | -395,141 | -385,664 | -387,423 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 6,303,271 | 6,458,415 | 6,141,616 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | 369,213 | 317,091 | 261,480 |
| Total Equity | 6,672,484 | 6,775,506 | 6,403,096 |
| Share capital awaiting retirement (unit: share) | 0 | 0 | 0 |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 37 | 38 | 38 |
